Clinical Trial Update: WS®1442 in Slightly Overweight Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating WS®1442 in slightly overweight subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight

Drugs mentioned

• WS®1442

Snippet

Sponsor: Dr. Willmar Schwabe GmbH & Co. KG | Conditions: Overweight | Phase 1 | Status: COMPLETED